BioCentury
ARTICLE | Company News

Molecular Templates, Threshold deal

March 24, 2017 8:07 PM UTC

Molecular Templates is reverse-merging with Threshold. The combined entity would keep Molecular Templates' name, and intends to change its NASDAQ ticker to MTEM. Existing Molecular Templates shareholders will own 66% of the combined company, while Threshold shareholders will own the remainder, subject to adjustments based on Threshold's net cash balance.

Longitude Capital is to invest $20 million, contingent on the company raising an additional $20 million in equity, upon the deal's anticipated close by 3Q17...